Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

WellPoint's Comparative Effectiveness Research Guidelines Describe How It Will Determine Usefulness Of Studies

This article was originally published in The Pink Sheet Daily

Executive Summary

The largest provider of health benefits in the U.S. will use the CER guidelines when evaluating drugs for its formulary.

You may also be interested in...



Venture Capitalists Have A Growing Interest In Comparative Effectiveness

Venture capitalists are taking a growing interest in the impact of comparative effectiveness research on future drug products and how results might affect products' ability to gain coverage by third-party payers

Venture Capitalists Have A Growing Interest In Comparative Effectiveness

Venture capitalists are taking a growing interest in the impact of comparative effectiveness research on future drug products and how results might affect products' ability to gain coverage by third-party payers

WellPoint Will Put Comparative Effectiveness Guidance In Updated Drug Assessment Criteria

The health insurer's next iteration of its technology assessment criteria, used for evaluating drugs for formulary inclusion, will likely be published by the end of the year.

Related Content

Topics

UsernamePublicRestriction

Register

PS070660

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel